Psoriatic arthritis treatment: biological response modifiers

PJ Mease, CE Antoni - Annals of the Rheumatic Diseases, 2005 - ard.bmj.com
In recent years there has been a surge of interest in the treatment of chronic inflammatory
disorders as a result of the development and application of targeted biological therapies …

[PDF][PDF] Psoriatic arthritis: current concepts on pathogenesis‐oriented therapeutic options

AM Turkiewicz, LW Moreland - Arthritis & Rheumatism, 2007 - Citeseer
Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy of the peripheral joints, spine,
and entheses, associated with psoriasis and characterized by diverse phenotypic subtypes …

Cytokine blockers in psoriatic arthritis

PJ Mease - Annals of the rheumatic diseases, 2001 - ard.bmj.com
The cellular events underlying the pathogenesis of psoriatic arthritis (PsA) and psoriasis
have not yet been fully elucidated. Nevertheless, some clues to these conditions are …

Evaluation and management of psoriatic arthritis: the role of biologic therapy

EM Ruderman - Journal of the American Academy of Dermatology, 2003 - Elsevier
Clinicians often view psoriatic arthritis (PsA) as a rather minor arthritic disorder because
many are unaware of the substantial damage, disability, and reduced quality of life that …

Psoriatic arthritis: latest treatments and their place in therapy

EJ Kang, A Kavanaugh - Therapeutic Advances in Chronic …, 2015 - journals.sagepub.com
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory disease that may affect
peripheral and axial joints, entheses, skin and nails, and other organs. Treatment with …

Role of novel biological therapies in psoriatic arthritis: effects on joints and skin

J Braun, J Sieper - BioDrugs, 2003 - Springer
Psoriatic arthritis (PsA) is a partly debilitating disease that may affect small and large joints
and the spine. Patients with PsA are divided into different subgroups according to joint …

[PDF][PDF] A short history of biological therapy for psoriatic arthritis

P Mease - Clin Exp Rheumatol, 2015 - clinexprheumatol.org
Psoriatic arthritis (PsA) is an inflammatory disease characterised by the clinical domains of
arthritis, enthesitis, dactylitis, spondylitis, and psoriasis, often causing significant functional …

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis

H Galadari, B Fuchs, M Lebwohl - International journal of …, 2003 - Wiley Online Library
Far from being a “benign” arthropathy, as it was initially characterized, psoriatic arthritis
(PsA) affects approximately 0.2% of the US population and can be associated with …

Psoriatic arthritis: recent progress in pathophysiology and drug development

DJ Veale - Arthritis research & therapy, 2013 - Springer
Psoriatic arthritis (PsA) is the second most common inflammatory arthropathy, after
rheumatoid arthritis diagnosis, in early arthritis clinics. Most patients have established …

Combination biologic treatment of refractory psoriasis and psoriatic arthritis

R Cuchacovich, I Garcia-Valladares… - The Journal of …, 2012 - jrheum.org
The pathophysiology of psoriasis and psoriatic arthritis (PsA) is dependent on a multistep
process that leads to chronic or recurrent inflammation1, 2, 3. Blockade of cytokines …